Columbia Asia Referral Hospital, Yeshwanthpur (CARHY) successfully conducted a Urology surgery through an advanced laser technology - HOLEP. The team of doctors led by Dr Manohar, Consultant Urologist at CARHY removed a large prostate gland weighing 350 gms, hitherto unheard of in medical history.
"HOLEP by 100 Watt Holmuim Laser technique that was used to treat the 72-year-old is an advanced laser technology and is the latest treatment for all urological problems. The advantages of the HOLEP 100 watt laser technique are multiple. The usage of this technique lessens hospital stay for a patient, less blood loss and most importantly leaves no scar on the patient's body. This technique provides less complications compared to the traditional way," says Dr Manohar.
The 72-year-old man Sanaj Nambiar (name changed) from Calicut was in immense pain due to enlarged prostate for over a decade. He was going through severe difficulties including pain while urinating, difficulty in walking and imbalance. While the normal size of the prostate gland is 15-20 gms, Nambiar was detected with 350 gm, which is unheard of in medical history.
The heavy prostrate made it difficult for Nambiar to carry out basic and normal activities of life. In addition, his kidneys were swollen due to obstruction by the grossly enlarged prostate. The family visited many hospitals and doctors in Kerala before deciding to get him treated at Bangalore. The abnormal size of the prostrate made many hospitals even in Bangalore apprehensive about conducting the critical surgery as the regular surgical process would cause bleeding and chances of its incomplete removal.
Finally, a family member recommended CARHY, which is known for its advanced technologies and expertise in the field of Urology.
His enlarged gland was removed in less than 2 hours of time without any blood loss. Nambiar was discharged from the hospital the next day. Today, he is leading a normal and active life without any complications.
Discovery of stem-like CD4 T cells offers new hope for cancer immunotherapy